Projects per year
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
EORTC MY20 quality of life questionnaire update
Stege, C., Oerlemans, S. & Zweegman, S.
1/01/2022 → 31/12/2023
Project: Research
-
A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies
Lameris, R., Ruben, J. M., Iglesias-Guimarais, V., de Jong, M., Veth, M., van de Bovenkamp, F. S., de Weerdt, I., Kater, A. P., Zweegman, S., Horbach, S., Riedl, T., Winograd, B., Roovers, R. C., Adang, A. E. P., de Gruijl, T. D., Parren, P. W. H. I. & van der Vliet, H. J., 21 Mar 2023, In: Cell Reports Medicine. 4, 3, p. 100961 100961.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Prognostic value of positron emission tomography/computed tomography in transplant-eligible newly diagnosed multiple myeloma patients from CASSIOPEIA: the CASSIOPET study
Kraeber-Bodéré, F., Zweegman, S., Perrot, A., Hulin, C., Caillot, D., Facon, T., Leleu, X., Belhadj, K., Itti, E., Karlin, L., Bailly, C., Levin, M-D., Minnema, M. C., Jamet, B., Bodet-Milin, C., de Keizer, B., Béné, M. C., Avet-Loiseau, H., Sonneveld, P., Pei, L., & 6 others, 1 Feb 2023, In: Haematologica. 108, 2, p. 621-626 6 p.Research output: Contribution to journal › Letter › Academic › peer-review
Open Access -
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review
Mian, H., McCurdy, A., Giri, S., Grant, S., Rochwerg, B., Winks, E., Rosko, A. E., Engelhardt, M., Pawlyn, C., Cook, G., Jackson, G., Bringhen, S., Facon, T., Larocca, A., Zweegman, S. & Wildes, T. M., 1 Dec 2023, In: Blood Cancer Journal. 13, 1, 6.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19
COBRA KAI Study Team, 1 Oct 2022, In: JAMA Oncology. 8, 10, p. 1477-1483 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access10 Citations (Scopus) -
Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma
Sonneveld, P., Zweegman, S., Cavo, M., Nasserinejad, K., Broijl, A., Troia, R., Pour, L., Croockewit, S., Corradini, P., Patriarca, F., Wu, K., Droogendijk, J., Bos, G., Hajek, R., Teresa Petrucci, M., Ypma, P., Zojer, N., Minnema, M. C. & Boccadoro, M., 30 Oct 2022, In: HemaSphere. 6, 10, p. E786Research output: Contribution to journal › Article › Academic › peer-review
Open Access